654 J ournal of Natural Products, 2003, Vol. 66, No. 5
Williams et al.
(41.8), L-lactic acid (18.5), D-lactic acid (31.5), N-Me-L-Phe
(31.2), and N-Me-D-Phe (33.5). The retention times of the
components in the hydrolysate were L-lactic acid (18.5), L-Val
(30.3), N-Me-L-Val (23.4), N-Me-D-Val (41.8), and N-Me-D-Phe
(33.5). The identities of the peaks were also confirmed by co-
injection.
Hz) 9.11 (1H, s), 8.93 (1H, d, 9.2), 8.55 (1H, d, 6.4), 7.55 (1H,
br s), 6.63 (1H, br s), 6.11 (1H, s), 4.30 (1H, m), 4.11 (1H, m),
2.85 (1H, m), 1.86 (2H, m), 1.70 (1H, m), 1.47 (2H, m), 1.27
(6H, m), 1.22 (3H, d, 7.1), 1.04 (3H, d, 5.7), 0.95 (3H, d, 5.9),
0.85 (3H, t, 8.0).
Absolu te Ster eoch em istr y of th e 3-Am in o-2-m eth yloct-
7-yn oic Acid . The hydrogenated hydrolysate was derivatized
with L-FDLA by the standard procedure and compared with
the derivatized synthetic standards.11 The analysis was carried
out by RP-HPLC [YMC-Pack AQ-ODS, 10 × 250 mm, 50%
MeCN in 0.01 N TFA, flow rate 2.5 mL/min, PDA detection].
The retention times (min) of the L-FDLA derivatized standards
were (2R,3S)-5 (25.7), (2S,3S)-5 (26.7), (2R,3R)-5 (45.6), and
(2S,3R)-5 (54.1)12 with the retention times of L-FDLA+-
(2R,3S)-5 and l-FDLA-(2S,3S)-5 being inferred from the reten-
tion times of D-FDLA+(2S,3R)-5 and d-FDLA+(2S,3S)-5 re-
spectively. The retention time of the â-amino acid in the
hydrolysate was 26.7 min (2S, 3S), the identity of which was
confirmed by co-injection of the (2S,3S)-5. The previously
identified amino acids appeared at 12.0 (L-Val), 15.1 (N-Me-
L-Val), and 20.5 min (N-Me-D-Val).
Ack n ow led gm en t. We would like to thank the Republic
of Palau for the marine research permit and the National
Cancer Institute for providing support through R01 grant
CA12623 and NCNPDDG grant CA53001. The upgrades to the
NMR spectrometers used in this research were funded by
grants from the CRIF Program of the National Science
Foundation (CHE9974921), the Air Force Office of Scientific
Research (F49620-01-1-0524), and the Elise Pardee Founda-
tion. The cyanobacterium was collected by J . Starmer and
identified with the assistance of E. Cruz-Rivera. G. Tien at
the University of Hawaii, Department of Chemistry carried
out the bioassays. The UCR Mass Spectrometry Facility,
Department of Chemistry, University of California, performed
the mass spectral analyses at Riverside.
Syn th esis of 3-Am in o-2-m eth ylocta n oic Acid . To 15 mL
of THF in a 100 mL flask under N2 were added trimethyl
phosphonoacetate (2) (5.5 mmol) and n-BuLi (5.6 mmol). After
stirring at -78 °C for 1 h, this mixture was cannulated into
20 mL of THF containing hexanal (5.5 mmol). The reaction
was allowed to warm to room temperature overnight. The
solvent was removed and the residue partitioned between
diethyl ether and water. The residue from the organic layer
was dissolved in a 20:1 mixture of petroleum ether/diethyl
ether and chromatographed on silica to yield pure methyl oct-
2(E)-enoate (3). This R,â-unsaturated ester was then treated
according to Davies’ procedure13 except the diastereomers were
not separated after methylation with KHMDS and iodomethane.
The C-2 diastereomers were separated after deprotection as
their FDLA derivatives in the manner previously described.
D-F DLA + (2R,3R)-3-Am in o-2-m eth ylocta n oic Acid : 1H
NMR (acteone-d6, 500 MHz) δ (integration, multiplicity, J in
Hz) 9.11 (1H, s), 8.93 (1H, d, 9.2), 8.55 (1H, d, 6.4), 7.55 (1H,
br s), 6.63 (1H, br s), 6.11 (1H, s), 4.26 (1H, m), 3.99 (1H, m),
2.96 (1H, m), 1.86 (2H, m), 1.68 (1H, m), 1.40 (2H, m), 1.30
(6H, m), 1.23 (3H, d, 6.3), 1.01 (3H, d, 5.9), 0.93 (3H, d, 5.7),
0.85 (3H, t, 7.2).
Su p p or tin g In for m a tion Ava ila ble: The 1H, 13C, and 2D NMR
data of 1 and the full model for Figure 1 are available free of charge
Refer en ces a n d Notes
(1) Staley, J . T.; Castenholz, R. W.; Colwell, R. R.; Holtz, J . G.; Cane, M.
D.; Pace, N. R.; Salyers, A. A.; Tiedje, J . M. The Microbial World:
Foundation of the Biosphere, a report from The American Acadamey
of Microbiology; 1997.
(2) Gerwick, W. H.; Tan, L. T.; Sitachitta, N. In The Alkaloids; Cordell,
G. A., Ed.; Academic Press: San Diego, 2001; Vol. 57, pp 75-184.
(3) The IC50 values for in vitro cytotoxicity were determined using the
sulforhodamine B assay. Skehan, P.; Storeng, R.; Scudiero, D.; Monks,
A.; McMahon, J .; Vistica, D.; Warren, J . T.; Bokesch, H.; Kenney, S.;
Boyd, M. R. J . Natl. Cancer Inst. 1990, 82, 1107-1112.
3
(4) Two HMBC experiments with J CH optimized for
7 and 4 Hz,
respectively, failed to show any correlation between C-1 and H-43.
(5) ROESY cross-peaks between H-37 and H-43 indicate a cis amide bond,
while correlations between H-44 and H-40 of the L-lactic acid and
adjacent N-Me-L-Val units indicate the two side chains are on the
same face of the molecule. Analysis of models suggested that H-40
was responsible for the latter correlation rather than the overlapping
H-34. Unfortunately too little material remains to conclusively
establish which methyl group shows a ROESY correlation to H-44.
(6) Agami, C.; Cheramy, S.; Dechoux, L.; Melaimi, M. Tetrahedron 2001,
57, 195-200.
(7) The methylation occurs predominantly from the re face of the enolate
to yield the anti R-methyl-â-amino acid as the major product. Cf.:
Davies 1994.
(8) Luesch, H.; Yoshida, W. Y.; Moore, R. E.; Paul, V. J .; Mooberry, S. L.
J . Nat. Prod. 2000, 63, 611-615.
(9) Luesch, H.; Yoshida, W. Y.; Moore, R. E.; Paul, V. J . J . Nat. Prod.
2000, 63, 1106-1112.
(10) Fernandez-Suarez, M.; Mun˜oz, L.; Fernandez, R.; Riguera, R. Tetra-
hedron: Asymmetry 1997, 8, 1847-1854, and references within.
(11) Fujii, K.; Yoshitomo, I.; Oka, H.; Suzuki, M.; Harada, K. Anal. Chem.
1997, 69, 5146-5151.
(12) The relative integration of the HPLC peaks after derivatization with
L- and DL-FDLA was used to determine the elution order of the AMO
standards. The major peaks were assigned as (2R, 3R) and ent-(2R,
3R).
L-F DLA + (2R,3R)-3-Am in o-2-m eth ylocta n oic Acid : 1H
NMR (acteone-d6, 500 MHz) δ (integration, multiplicity, J in
Hz) 9.11 (1H, s), 8.91 (1H, d, 8.9), 8.61 (1H, d, 6.3), 7.54 (1H,
br s), 6.73 (1H, br s), 6.11 (1H, s), 4.26 (1H, m), 3.98 (1H, m),
2.93 (1H, m), 1.89 (2H, m), 1.68 (1H, m), 1.44 (2H, m), 1.31
(6H, m), 1.20 (3H, d, 7.3), 1.02 (3H, d, 6.2), 0.94 (3H, d, 6.1),
0.85 (3H, t, 7.9).
D-F DLA + (2S,3R)-3-Am in o-2-m eth ylocta n oic Acid : 1H
NMR (acteone-d6, 500 MHz) δ (integration, multiplicity, J in
Hz) 9.10 (1H, s), 8.54 (1H, d, 8.9), 8.52 (1H, d, 5.5), 7.71 (1H,
br s), 6.64 (1H, br s), 6.20 (1H, s), 4.35 (1H, m), 4.25 (1H, m),
2.92 (1H, m), 1.84 (2H, m), 1.68 (1H, m), 1.40 (2H, m), 1.30
(6H, m), 1.23 (3H, d, 7.0), 1.02 (3H, d, 6.0), 0.94 (3H, d, 6.2),
0.83 (3H, t, 7.0).
(13) Davies, S. G.; Walters, I. A. S. J . Chem. Soc., Perkins Trans. 1 1994,
9, 1129-1139.
L-F DLA + (2S,3R)-3-Am in o-2-m eth ylocta n oic Acid : 1H
NMR (acteone-d6, 500 MHz) δ (integration, multiplicity, J in
NP030050S